Complete Revascularization (CR) Versus Culprit-Only Percutaneous Coronary Intervention (CO-PCI) in NSTE-ACS with

Kesar Prajapati1, Shanmukh Sai Pavan Lingamsetty2, Harshith Thyagaturu3

  • 1Internal Medicine, Metropolitan Hospital Center, NYC Health + Hospital, New York, New York, USA.

Insights

Complete revascularization (CR) significantly reduces mortality and reinfarction in Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS) patients with multivessel disease. This strategy is superior to culprit vessel only-Percutaneous Coronary Intervention (CO-PCI).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Complete revascularization (CR) is proven effective in ST-Elevation Myocardial Infarction (STEMI).
  • The benefit of CR versus culprit vessel only-Percutaneous Coronary Intervention (CO-PCI) in Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS) with multivessel disease is not well-established.
  • This meta-analysis addresses the optimal revascularization strategy in NSTE-ACS.

Purpose of the Study:

  • To compare the efficacy of CR versus CO-PCI in NSTE-ACS patients with multivessel disease.
  • To evaluate the impact of CR on mortality, myocardial reinfarction, and other adverse cardiovascular events.

Main Methods:

  • A systematic literature search was conducted across PubMed, Embase, and Cochrane databases.
  • Eleven studies involving 36,997 NSTE-ACS patients were included.
  • A random-effects model was used for meta-analysis, calculating risk ratios (RR) and 95% confidence intervals (CI).

Main Results:

  • CR significantly reduced all-cause mortality (RR: 0.66; 95% CI: 0.55 to 0.79).
  • Myocardial reinfarction rates were lower with CR (RR: 0.57; 95% CI: 0.43 to 0.76).
  • CR also led to a reduction in composite endpoints (RR: 0.72; 95% CI: 0.63 to 0.82) and repeat revascularization (RR: 0.60; 95% CI: 0.54 to 0.66).

Conclusions:

  • Complete revascularization is associated with improved outcomes in NSTE-ACS patients with multivessel disease.
  • CR demonstrates a significant reduction in all-cause mortality, recurrent myocardial infarction, composite outcomes, and the need for repeat revascularization compared to CO-PCI.
  • These findings support CR as the preferred strategy in this patient population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655